Filter Type: All Time (3 Results) Past 24 Hours Past Week Past month Post Your Comments?
SAN RAFAEL, Calif., Dec. 15, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN), a global leader in providing therapies for rare genetic diseases, today announced the appointment of former CEO of Celgene Corporation, Mark Alles, to its Board of Directors effective January 1, 2022.
Preview / Show more
Updated: 7 hours ago
To reach a BioMarin RareConnections® case manager, please call, toll-free, 1-866-906-6100 or e-mail support@biomarin-rareconnections.com. For more information about Voxzogo, please visit www.voxzogo.com. For additional information regarding this product, please contact BioMarin Medical Information at [email protected]. About Achondroplasia
Preview / Show more
Updated: just now
See Also:Approval Code Phone Number, Verify It Show details
SAN RAFAEL, Calif. and SHANGHAI, Dec. 16, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) and Skyline Therapeutics (formerly Geneception), a gene and cell therapy company focused ...
Preview / Show more
Updated: 1 hours ago
See Also:Strategic Inc Phone Number, Show details
All Time (3 Results) Past 24 Hours Past Week Past month